Investigation of the Efficacy of Video-Based Exercise Program in Degenerative Meniscus Tear

Meniscus Tear Clinical Trial

Official title:

Investigation of the Efficacy of Video-Based Exercise Program in Degenerative Meniscus Tear

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT05266365
• Other study ID #: 107
• Status: Enrolling by invitation
• Phase: N/A
• Start date: April 1, 2022
• Est. completion date: September 30, 2023

Study information

• Verified date: August 2023
• Source: Istanbul University - Cerrahpasa (IUC)
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This randomized-controlled trial aims to investigate the efficacy of video-based exercise program in patients with degenerative meniscus tear.

Description:

To investigate the efficacy of video-based exercise program, voluntary patients with degenerative meniscus tear, aged between 40-65 years will be randomly divided into two groups: Video-based exercise (VBE) group and standard exercise (SE) group. Interventions will be applied for 16 sessions (twice a week for 8 weeks). The patients will be assessed at baseline and at the end of the 8-week intervention. The pain on activity, at rest and at night will be assessed with Visual Analog Scale (VAS). Active range of motion will be assessed with a digital goniometer. Isometric muscle strength will be measured with a handheld dynamometer. The functional status and symptoms will be evaluated by The Knee Injury and Osteoarthritis Outcome Score (KOOS) and Lysholm Knee Scoring Scale. Health related quality of life will be assessed with Short Form-12 (SF-12).

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 50
• Est. completion date: September 30, 2023
• Est. primary completion date: November 30, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 65 Years

Eligibility

Inclusion Criteria:

• Being aged between 40 and 65 years
• Having the degenerative meniscus tear in at least one knee
• Having body mass index in the range of 18-30 kg/m2
• Feeling the pain that lasts for at least 2 months
• Having grade 1 or grade 2 degenerative meniscal tear diagnosed by an orthopedic specialist according to the MRI results
• Having the activity level is between 1 and 5 according to the Tegner Activity Scale
• Having the ability to read and write Turkish

Exclusion Criteria:

• Having undergone arthroscopic partial meniscectomy surgery due to degenerative meniscal tear
• Participating in a physiotherapy program for degenerative meniscal tear in the last 12 weeks
• Have received steroid injections in the last 6 months
• Accompanying conditions such as injury to the surrounding ligaments, congenital anomaly in the affected knee, coxarthrosis and spinal stenosis
• Presence of any systemic disorder that may affect assessment parameters
• Failure to cooperate with assessments
• Any vision or hearing problem that would prevent them from adapting to the assessment

Related Conditions & MeSH terms

• Degenerative Disease
• Knee Pain Swelling
• Meniscus Tear

Intervention

Other:
• Video-based exercise program
A 8-week exercise program used in conservative treatment of degenerative meniscus tear will be performed. A video record will be prepared by the physiotherapist to the patients where each exercise will be described in detail. This video record will be watched in the clinic and the patients will do video-baed exercises by following th instructions in the video. The patient will be performed the exercises without any the verbal and visual commands of the physiotherapist, who is in the clinic.
• Standard exercise program
A 8-week exercise program used in conservative treatment of degenerative meniscus tear will be performed. The patients will do exercises under control of the physiotherapist in the clinic. The patient will be performed the exercises with the verbal and visual commands of the physiotherapist.

Locations

Country	Name	City	State
Turkey	Istanbul University-Cerrahpasa	Istanbul	Bakirkoy

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul University - Cerrahpasa (IUC)

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Knee Injury and Osteoarthritis Outcome Score (KOOS)	Short-term and long-term symptoms and function will be assessed with the Knee injury and Osteoarthritis Outcome Score (KOOS) that is developed as an extension of the WOMAC Osteoarthritis Index. The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.	Baseline
Secondary	Knee Injury and Osteoarthritis Outcome Score (KOOS)	Short-term and long-term symptoms and function will be assessed with the Knee injury and Osteoarthritis Outcome Score (KOOS) that is developed as an extension of the WOMAC Osteoarthritis Index. The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.	At the end of 8-week intervention
Secondary	Visual Analogue Scale (VAS)	Pain intensity will be measured using the visual analogue scale (VAS). The participants will be asked to indicate their perceived pain at rest, during activity and at night on the 10 cm line between no pain and terrible pain. The score will be determined by measuring the distance on 10 cm line using a ruler. The higher scores indicate an higher level of pain.	Baseline
Secondary	Visual Analogue Scale (VAS)	Pain intensity will be measured using the visual analogue scale (VAS). The participants will be asked to indicate their perceived pain at rest, during activity and at night on the 10 cm line between no pain and terrible pain. The score will be determined by measuring the distance on 10 cm line using a ruler. The higher scores indicate an higher level of pain.	After 8-week intervention
Secondary	Active Range of Motion	Active knee range of motion including flexion and extension will be measured described by the American Academy of Orthopaedic Surgeons (AAOS) using a digital goniometer.	Baseline
Secondary	Active Range of Motion	Active knee range of motion including flexion and extension will be measured described by the American Academy of Orthopaedic Surgeons (AAOS) using a digital goniometer.	At the end of 8-week intervention
Secondary	Muscle Strength	Isometric muscle strength will be measured with a handheld dynamometer for knee flexors and extensors. The process will be repeated three times in each direction, with the average value recorded.	Baseline
Secondary	Muscle Strength	Isometric muscle strength will be measured with a handheld dynamometer for knee flexors and extensors. The process will be repeated three times in each direction, with the average value recorded.	At the end of the 8-week intervention
Secondary	Lysholm Score	Functional limitations related to degenerative meniscal tear will be used with the Lysholm Score that is one of the most frequently used functional questionnaires. The total score is the sum of each response to the eight questions, and may range from 0-100. Higher scores indicate a better outcome with fewer symptoms or disability.	Baseline
Secondary	Lysholm Score	Functional limitations related to degenerative meniscal tear will be used with the Lysholm Score that is one of the most frequently used functional questionnaires. The total score is the sum of each response to the eight questions, and may range from 0-100. Higher scores indicate a better outcome with fewer symptoms or disability.	At the end of the 8-week intervention
Secondary	Short Form-12 (SF-12)	Short Form-12 (SF-12), which is developed based on Short Form-36, consists of 12 items: 7 items dealing with the physical components scores (PCS-12) and 5 items related to the mental components scores (MCS-12) of SF-12. Range of both scores is 0 to 100, where the higher scores indicate better health related quality of life.	Baseline
Secondary	Short Form-12 (SF-12)	Short Form-12 (SF-12), which is developed based on Short Form-36, consists of 12 items: 7 items dealing with the physical components scores (PCS-12) and 5 items related to the mental components scores (MCS-12) of SF-12. Range of both scores is 0 to 100, where the higher scores indicate better health related quality of life.	At the end of the 8-week intervention